Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain

A major goal of research on addiction is to identify the molecular mechanisms of long‐lasting behavioural alterations induced by drugs of abuse. Cocaine and delta‐9‐tetrahydrocannabinol (THC) activate extracellular signal‐regulated kinase (ERK) in the striatum and blockade of the ERK pathway prevents establishment of conditioned place preference to these drugs. However, it is not known whether activation of ERK in the striatum is specific for these two drugs and/or this brain region. We studied the appearance of phospho‐ERK immunoreactive neurons in CD−1 mouse brain following acute administration of drugs commonly abused by humans, cocaine, morphine, nicotine and THC, or of other psychoactive compounds including caffeine, scopolamine, antidepressants and antipsychotics. Each drug generated a distinct regional pattern of ERK activation. All drugs of abuse increased ERK phosphorylation in nucleus accumbens, lateral bed nucleus of the stria terminalis, central amygdala and deep layers of prefrontal cortex, through a dopamine D1 receptor‐dependent mechanism. Although some non‐addictive drugs moderately activated ERK in a few of these areas, they never induced this combined pattern of strong activation. Antidepressants and caffeine activated ERK in hippocampus and cerebral cortex. Typical antipsychotics mildly activated ERK in dorsal striatum and superficial prefrontal cortex, whereas clozapine had no effect in the striatum, but more widespread effects in cortex and amygdala. Our results outline a subset of structures in which ERK activation might specifically contribute to the long‐term effects of drugs of abuse, and suggest mapping ERK activation in brain as a way to identify potential sites of action of psychoactive drugs.

[1]  N. Volkow,et al.  The neuroscience of addiction , 2005, Nature Neuroscience.

[2]  B. Roques,et al.  Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice , 2003, British journal of pharmacology.

[3]  R. Polakiewicz,et al.  Behavioral/systems/cognitive Brain Region-specific Mechanisms for Acute Morphine- Induced Mitogen-activated Protein Kinase Modulation and Distinct Patterns of Activation during Analgesic Tolerance and Locomotor Sensitization Opioid-receptor Activation in Cell Lines Results in Phosphorylation of P42/ , 2022 .

[4]  P. Greengard,et al.  Opposite regulation by typical and atypical anti‐psychotics of ERK1/2, CREB and Elk‐1 phosphorylation in mouse dorsal striatum , 2003, Journal of neurochemistry.

[5]  J. Girault,et al.  Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction. , 2003 .

[6]  E. Nestler,et al.  Regulation of CRE‐mediated transcription in mouse brain by amphetamine , 2003, Synapse.

[7]  J. Girault,et al.  Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus , 2003, The Journal of Neuroscience.

[8]  P. Soubrié,et al.  Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex , 2003, The European journal of neuroscience.

[9]  D. David,et al.  Antidepressant-like effects in various mice strains in the forced swimming test , 2003, Psychopharmacology.

[10]  R. Malenka,et al.  Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.

[11]  I. McGregor,et al.  Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain , 2003, Neuropharmacology.

[12]  R. Wise Brain Reward Circuitry Insights from Unsensed Incentives , 2002, Neuron.

[13]  W. Schultz Getting Formal with Dopamine and Reward , 2002, Neuron.

[14]  L. Mao,et al.  Amphetamine Increases Phosphorylation of Extracellular Signal-regulated Kinase and Transcription Factors in the Rat Striatum via Group I Metabotropic Glutamate Receptors , 2002, Neuropsychopharmacology.

[15]  C. Brignell,et al.  Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users , 2002, Psychopharmacology.

[16]  John Q. Wang,et al.  CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons , 2002, Neuroreport.

[17]  John N. J. Reynolds,et al.  Dopamine-dependent plasticity of corticostriatal synapses , 2002, Neural Networks.

[18]  David P Wolfer,et al.  Knockout of ERK1 MAP Kinase Enhances Synaptic Plasticity in the Striatum and Facilitates Striatal-Mediated Learning and Memory , 2002, Neuron.

[19]  R. Maldonado,et al.  Cannabinoid Addiction: Behavioral Models and Neural Correlates , 2002, The Journal of Neuroscience.

[20]  Barry J. Everitt,et al.  Psychomotor Stimulant Addiction: A Neural Systems Perspective , 2002, The Journal of Neuroscience.

[21]  M. Barrot,et al.  Regional and Cellular Mapping of cAMP Response Element-Mediated Transcription during Naltrexone-Precipitated Morphine Withdrawal , 2002, The Journal of Neuroscience.

[22]  Mark J. Thomas,et al.  Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine , 2001, Nature Neuroscience.

[23]  N. Jamshidi,et al.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.

[24]  L. Vanderschuren,et al.  A single exposure to morphine induces long‐lasting behavioural and neurochemical sensitization in rats , 2001, The European journal of neuroscience.

[25]  S. Hyman,et al.  Addiction and the brain: The neurobiology of compulsion and its persistence , 2001, Nature Reviews Neuroscience.

[26]  J. Wickens,et al.  A cellular mechanism of reward-related learning , 2001, Nature.

[27]  D. Ji,et al.  Synaptic Plasticity and Nicotine Addiction , 2001, Neuron.

[28]  M. Besson,et al.  Δ9‐tetrahydrocannabinol‐induced MAPK/ERK and Elk‐1 activation in vivo depends on dopaminergic transmission , 2001, The European journal of neuroscience.

[29]  Mark A. Ungless,et al.  Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons , 2001, Nature.

[30]  Eric J. Nestler,et al.  Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.

[31]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[32]  M. Besson,et al.  Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties , 2000, The Journal of Neuroscience.

[33]  M. Parmentier,et al.  Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice , 2000, The European journal of neuroscience.

[34]  G. Di Chiara,et al.  Stimulation of In Vivo Dopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs , 2000, The Journal of Neuroscience.

[35]  A. Frazer Norepinephrine involvement in antidepressant action. , 2000, The Journal of clinical psychiatry.

[36]  Mark J. Thomas,et al.  Modulation of Long-Term Depression by Dopamine in the Mesolimbic System , 2000, The Journal of Neuroscience.

[37]  H. Mansvelder,et al.  Long-Term Potentiation of Excitatory Inputs to Brain Reward Areas by Nicotine , 2000, Neuron.

[38]  J. Kauer,et al.  Amphetamine Blocks Long-Term Synaptic Depression in the Ventral Tegmental Area , 2000, The Journal of Neuroscience.

[39]  Marc Parmentier,et al.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors , 2000, British journal of pharmacology.

[40]  S. Hyman,et al.  Addiction, Dopamine, and the Molecular Mechanisms of Memory , 2000, Neuron.

[41]  L. Vanderschuren,et al.  A Single Exposure to Amphetamine Is Sufficient to Induce Long-Term Behavioral, Neuroendocrine, and Neurochemical Sensitization in Rats , 1999, The Journal of Neuroscience.

[42]  S. File,et al.  Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety , 1999, The European journal of neuroscience.

[43]  B. Prasad,et al.  Neurotrophin-3 Contributes to the Initiation of Behavioral Sensitization to Cocaine by Activating the Ras/Mitogen-Activated Protein Kinase Signal Transduction Cascade , 1999, The Journal of Neuroscience.

[44]  P. Blier,et al.  Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study , 1999, Psychopharmacology.

[45]  E. Zvartau,et al.  Caffeine place conditioning in rats: comparison with cocaine and ethanol , 1998, European Neuropsychopharmacology.

[46]  D. A. King,et al.  Cocaine and Caffeine Conditioned Place Preference, Locomotor Activity, and Additivity , 1998, Pharmacology Biochemistry and Behavior.

[47]  B. Fredholm,et al.  Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.

[48]  V. Höllt,et al.  Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine‐dependent rats in vivo , 1998, The European journal of neuroscience.

[49]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[50]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[51]  W. Schultz Dopamine neurons and their role in reward mechanisms , 1997, Current Opinion in Neurobiology.

[52]  A M Graybiel,et al.  Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  L. Angelis Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[54]  B. Costall,et al.  Muscarinic antagonists are anxiogenic in rats tested in the black-white box , 1996, Pharmacology Biochemistry and Behavior.

[55]  R. Malenka,et al.  Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens , 1994, Nature.

[56]  H. Lublin,et al.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment , 1993, Psychopharmacology.

[57]  J. Hietala,et al.  Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists. , 1993, European journal of pharmacology.

[58]  H. Akil,et al.  A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1992, Neuroscience.

[59]  H. Akil,et al.  A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1991, Neuroscience.

[60]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[62]  K. Mueller,et al.  Scopolamine produces locomotor stereotypy in an open field but apomorphine does not , 1990, Pharmacology Biochemistry and Behavior.

[63]  L. Heimer,et al.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata , 1988, Neuroscience.

[64]  T. Chase,et al.  The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand , 1988, Neuroscience.

[65]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Uzan,et al.  Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic postsynaptic receptors , 1979, Neuropharmacology.

[67]  I. McGregor,et al.  Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. , 2003, Neuropharmacology.

[68]  E. Valjent,et al.  Mitogen-activated protein kinase/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory? , 2001, Molecular neurobiology.

[69]  E. Valjent,et al.  A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice , 2000, Psychopharmacology.

[70]  E. Valjent,et al.  A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. , 2000, Psychopharmacology.

[71]  B. Kieffer Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.

[72]  G. Di Chiara Drug addiction as dopamine-dependent associative learning disorder. , 1999, European journal of pharmacology.

[73]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[74]  L. Heimer,et al.  Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.